Strategic Wealth Advisors Group LLC grew its stake in HCP, Inc. (NYSE:HCP) by 4.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,760 shares of the real estate investment trust’s stock after acquiring an additional 473 shares during the period. Strategic Wealth Advisors Group LLC’s holdings in HCP were worth $420,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in HCP. Quest Capital Management Inc. ADV acquired a new stake in HCP during the third quarter worth approximately $28,000. Westside Investment Management Inc. acquired a new stake in HCP during the second quarter worth approximately $31,000. NEXT Financial Group Inc raised its position in shares of HCP by 181.3% in the second quarter. NEXT Financial Group Inc now owns 1,125 shares of the real estate investment trust’s stock valued at $36,000 after buying an additional 725 shares in the last quarter. CSat Investment Advisory L.P. raised its position in shares of HCP by 77.6% in the second quarter. CSat Investment Advisory L.P. now owns 1,165 shares of the real estate investment trust’s stock valued at $37,000 after buying an additional 509 shares in the last quarter. Finally, Parallel Advisors LLC raised its position in shares of HCP by 29.9% in the third quarter. Parallel Advisors LLC now owns 1,364 shares of the real estate investment trust’s stock valued at $49,000 after buying an additional 314 shares in the last quarter. Institutional investors own 95.80% of the company’s stock.
A number of research firms have recently weighed in on HCP. Scotiabank set a $38.00 price target on shares of HCP and gave the company a “buy” rating in a research report on Monday, September 30th. Zacks Investment Research upgraded shares of HCP from a “hold” rating to a “buy” rating and set a $39.00 price target for the company in a research report on Monday, October 14th. Morgan Stanley lifted their price target on shares of HCP from $32.00 to $35.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 17th. KeyCorp lifted their price target on shares of HCP from $34.00 to $37.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Finally, JPMorgan Chase & Co. upgraded shares of HCP from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $35.00 to $38.00 in a research report on Tuesday, October 8th. Two analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $36.78.
NYSE:HCP traded down $0.89 during mid-day trading on Friday, reaching $33.64. The stock had a trading volume of 4,003,528 shares, compared to its average volume of 2,801,829. The stock has a 50-day simple moving average of $36.24 and a two-hundred day simple moving average of $33.42. The stock has a market capitalization of $17.57 billion, a PE ratio of 18.48, a P/E/G ratio of 6.81 and a beta of 0.22. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.81 and a quick ratio of 0.81. HCP, Inc. has a 12 month low of $26.58 and a 12 month high of $37.93.
HCP (NYSE:HCP) last announced its quarterly earnings data on Wednesday, October 30th. The real estate investment trust reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.52). The firm had revenue of $538.00 million during the quarter, compared to the consensus estimate of $503.65 million. HCP had a net margin of 43.66% and a return on equity of 12.78%. The business’s revenue was up 18.0% compared to the same quarter last year. During the same period last year, the business earned $0.44 earnings per share. Equities analysts expect that HCP, Inc. will post 1.75 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 19th. Investors of record on Monday, November 4th will be paid a $0.37 dividend. The ex-dividend date of this dividend is Friday, November 1st. This represents a $1.48 dividend on an annualized basis and a yield of 4.40%. HCP’s dividend payout ratio (DPR) is 81.32%.
In related news, COO Thomas Klaritch sold 35,014 shares of HCP stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $36.02, for a total value of $1,261,204.28. Following the transaction, the chief operating officer now directly owns 230,529 shares of the company’s stock, valued at $8,303,654.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.13% of the company’s stock.
HCP Company Profile
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Read More: What is the Quick Ratio?
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.